On November 6, 2024, Anthony Vuoto, a Director at iRadimed Corp (IRMD, Financial), executed a sale of 2,690 shares of the company. The transaction was filed on the same day with the SEC. Following this sale, the insider now owns 14,234 shares of iRadimed Corp.
iRadimed Corp is known for its development, manufacture, and sale of innovative magnetic resonance imaging (MRI) compatible medical devices and related accessories and services. The company's offerings include non-magnetic intravenous (IV) infusion pump systems that are specifically designed to be safe for use during MRI procedures.
Over the past year, Anthony Vuoto has sold a total of 5,745 shares and has not made any purchases of the company's stock. This recent transaction is part of a broader trend observed within iRadimed Corp, where there have been no insider buys but 13 insider sells over the past year.
On the valuation front, iRadimed Corp's shares were trading at $55.99 on the day of the sale, giving the company a market cap of approximately $712.244 million. The price-earnings ratio stands at 38.49, which is above the industry median of 29.03. The stock's GF Value is estimated at $52.52, indicating a price-to-GF-Value ratio of 1.07, suggesting that the stock is Fairly Valued.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale might be of interest to investors tracking insider behaviors and company valuation metrics to gauge potential future stock movements and overall company health.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
